Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fu Mai Ning
- Development stage
- Unknown
- Lead developer
- Fosun Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fu Mai Ning is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of cardiovascular conditions, specifically cardiac arrhythmias such as premature ventricular contractions and palpitations. The formulation typically consists of several herbal extracts, including *Radix Puerariae* (Kudzu root), *Radix Salviae Miltiorrhizae* (Danshen), *Radix Panacis Quinquefolii* (American Ginseng), and *Nardostachys jatamansi*. It is designed to improve myocardial blood flow, reduce myocardial oxygen consumption, and stabilize cardiac rhythm. Pharmacologically, its components are known to modulate cardiac ion channels and exert anti-ischemic effects. It is commonly prescribed in China for patients with coronary heart disease or viral myocarditis presenting with irregular pulses.
- Brand names
- Fu Mai Ning
- Other names
- FumainingFu Mai Ning Capsule
02
Targets
MEK1 (Dual specificity mitogen-activated protein kinase kinase 1)MEK2 (Dual specificity mitogen-activated protein kinase kinase 2)
Beyond the preview
Go deeper on Fu Mai Ning.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fu Mai Ning.